Park J, Bae C W, Choi Y M
Department of Pediatrics, College of Medicine, Kyunghee University, Seoul, Korea.
J Korean Med Sci. 1998 Apr;13(2):123-30. doi: 10.3346/jkms.1998.13.2.123.
In order to observe the effects of serum albumin and fibrinogen on biophysical surface properties and the morphology of pulmonary surfactant in vitro, we measured the surface adsorption rate, dynamic minimum and maximum surface tension (min-, max-ST) by Pulsating Bubble Surfactometer, and demonstrated ultrastructures on a series of mixtures with varying concentrations of albumin or fibrinogen and Surfactant-TA. The albumin and fibrinogen significantly inhibited the adsorption rate and ST-lowering properties of surfactant through increasing STs of adsorption rate, min-ST, and max-ST. The characteristic morphology of the Surfactant-TA changed from lamellar rod-like structure with open ends into spherical structures with loss of their open ends by mixing with albumin or fibrinogen. These inhibitory effects of albumin and fibrinogen on surface properties of surfactant were dependent upon the increasing concentration of albumin or fibrinogen. We concluded that albumin and fibrinogen significantly altered surfactant function and its ultrastructural morphology in vitro. These findings support the concept that albumin and fibrinogen-induced surfactant dysfunction may play an important role in the pathophysiology of adult respiratory distress syndrome, and this adverse effect of albumin and fibrinogen on surfactant might be overcome by administration of large doses of exogenous surfactant.
为了在体外观察血清白蛋白和纤维蛋白原对肺表面活性剂生物物理表面特性及形态的影响,我们用脉动气泡表面张力仪测量了表面吸附率、动态最小和最大表面张力(最小、最大表面张力),并展示了一系列含有不同浓度白蛋白或纤维蛋白原与表面活性剂TA混合物的超微结构。白蛋白和纤维蛋白原通过提高吸附率、最小表面张力和最大表面张力的表面张力,显著抑制了表面活性剂的吸附率和降低表面张力的特性。通过与白蛋白或纤维蛋白原混合,表面活性剂TA的特征形态从具有开放末端的层状棒状结构变为失去开放末端的球形结构。白蛋白和纤维蛋白原对表面活性剂表面特性的这些抑制作用取决于白蛋白或纤维蛋白原浓度的增加。我们得出结论,白蛋白和纤维蛋白原在体外显著改变了表面活性剂的功能及其超微结构形态。这些发现支持了这样一种观点,即白蛋白和纤维蛋白原诱导的表面活性剂功能障碍可能在成人呼吸窘迫综合征的病理生理学中起重要作用,并且白蛋白和纤维蛋白原对表面活性剂的这种不利影响可能通过给予大剂量外源性表面活性剂来克服。